Ms Nedra Jolyn Miller, A-APRN | |
5341 Grand Blvd Ste 105, New Port Richey, FL 34652-4004 | |
(800) 470-6846 | |
(727) 478-0618 |
Full Name | Ms Nedra Jolyn Miller |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 5341 Grand Blvd Ste 105, New Port Richey, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366425100 | NPI | - | NPPES |
Y1129 | Other | FL | BCBS |
103394200 | Medicaid | FL |
Mailing Address | Practice Location Address |
---|---|
Ms Nedra Jolyn Miller, A-APRN 5341 Grand Blvd Ste 105, New Port Richey, FL 34652-4004 Ph: (727) 478-0648 | Ms Nedra Jolyn Miller, A-APRN 5341 Grand Blvd Ste 105, New Port Richey, FL 34652-4004 Ph: (800) 470-6846 |
News Archive
The Group of Seven industrialized nations on Friday plans to sign an agreement to provide $1.5 billion to develop vaccines for diseases - including HIV/AIDS, TB and malaria - that largely affect developing countries, the government of Italy announced on Tuesday, Reuters reports.
Social isolation and loneliness have affected many people during the Covid-19 pandemic, especially those with limited access to digital technology.
New research published in the journal Nature, could pave the way to world's first genetically modified human baby. The research involves making embryos with genes from one man and two women. There are hundreds or families around the world who are left childless or have serious ill babies because they carry genes for hereditary illnesses. This research may bring hope to such couples. According to scientists on the team, within the next three years these women will be able to avail such techniques. There has been skepticism regarding ethical issues attached to making of "designer babies".
The Department of Health & Human Services' Agency for Healthcare Research and Quality (AHRQ) has awarded a three-year demonstration grant for not-for-profit entities to Fairview Health Services in Minneapolis to extend a national collaborative that is reducing birth-related injuries.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
› Verified 6 days ago